Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | VCAM1 | P19320 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.47 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.47 |
| ▸ | GRM6 | O15303 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HSPB1 | P04792 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL404745 | 0.85 | VCAM1 (0.64) | TDP1ATMVCAM1MAPTGRIA1 | |
| SCHEMBL27455671 | 0.83 | TDP1 (0.60) | TDP1ATMVCAM1MAPTALDH1A1 | |
| SCHEMBL4648670 | 0.81 | TDP1 (0.58) | TDP1ATMVCAM1MAPTALDH1A1 | |
| SCHEMBL16962514 | 0.81 | TDP1 (0.58) | TDP1ATMVCAM1MAPTALDH1A1 | |
| SCHEMBL4385438 | 0.79 | VCAM1 (0.61) | TDP1VCAM1MAPTGRIA1GRIA2 | |
| SCHEMBL698847 | 0.79 | VCAM1 (0.66) | TDP1VCAM1MAPTGRIA1GRIA2 | |
| SCHEMBL10877621 | 0.79 | MAPT (0.53) | TDP1VCAM1MAPTGRIA1GRIA2 | |
| SCHEMBL589476 | 0.79 | VCAM1 (0.48) | TDP1ATMVCAM1MAPTGRIA1 | |
| SCHEMBL591089 | 0.79 | MAOA (0.44) | TDP1ATMVCAM1MAPTGRIA1 | |
| SCHEMBL1335475 | 0.79 | MAPT (0.49) | TDP1ATMVCAM1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136595-A1 | ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 | ENLIVEN INC. | 2025-05-01 | — | — | US | disclosed |
| WO-2025021182-A1 | CYP11A1 INHIBITORS | ACERAND THERAPEUTICS (HONG KONG) LIMITED (CN) | 2025-01-30 | — | — | WO | disclosed |
| EP-4476211-A1 | ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 | Enliven Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| US-RE49934-E1 | Inhibitors of cellular metabolic processes | SERVIER PHARMACEUTICALS LLC (US) | 2024-04-23 | — | — | US | disclosed |
| EP-3568390-B1 | SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) | 2024-03-06 | — | — | EP | disclosed |
| US-11806337-B2 | Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof | Sanford Burnham Prebys Medical Discovery Institute (US) | 2023-11-07 | — | — | US | disclosed |
| WO-2023154124-A1 | ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 | ENLIVEN THERAPEUTICS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230116770-A1 | SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute | 2023-04-13 | — | — | US | disclosed |
| CN-115746000-A | Compounds and methods for modulating bruton's tyrosine kinase | 嘉兴和剂药业有限公司 | 2023-03-07 | — | — | CN | disclosed |
| WO-2022266458-A1 | 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |
| US-RE31455-E | 2-Chloro-a,a,a-trifluoro-p-tolyl-3-carboxy-4-nitrophenyl ether; agronomical; selective weed control | ROHM AND HAAS COMPANY (US) | 1983-12-06 | — | — | US | disclosed |
| US-4415354-A | PREEMERGENCE AND POSTEMERGENCE HERBICIDES | ROHM AND HAAS COMPANY (US) | 1983-11-15 | — | — | US | disclosed |
| US-4358308-A | PREEMERGENT AND POSTEMERGENT APPLICATION | ROHM AND HAAS COMPANY (US) | 1982-11-09 | — | — | US | disclosed |
| US-4350522-A | Herbicidal 4-trifluoromethyl-4'-nitrodiphenyl ethers | ROHM AND HAAS COMPANY (US) | 1982-09-21 | — | — | US | disclosed |
| US-4330324-A | PREEMERGENCE APPLICATION | ROHM AND HAAS COMPANY (US) | 1982-05-18 | — | — | US | disclosed |
| US-4220468-A | Herbicidal 4-trifluoromethyl-4-nitrodiphenyl ethers | ROHM AND HAAS COMPANY (US) | 1980-09-02 | — | — | US | disclosed |
| US-4185995-A | Herbicidal 4-trifluoromethyl-4'nitrodiphenyl ethers | ROHM AND HAAS COMPANY (US) | 1980-01-29 | — | — | US | disclosed |
| US-4093446-A | Herbicidal 4-trifluoromethyl-4-nitrodiphenyl ethers | ROHM AND HAAS COMPANY (US) | 1978-06-06 | — | — | US | disclosed |
| US-4063929-A | Herbicidal 4-trifluoromethyl-4'nitrodiphenyl ethers | ROHM AND HAAS COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4046798-A | Herbicidal 4-trifluoromethyl-4'nitrodiphenyl ethers | ROHM AND HAAS COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136595-A1 | ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 | ERBB2, ERBB3, ERBB4 | TDP1 4116/4885ATM 579/4885VCAM1 4683/4885 |
| US-11806337-B2 | Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof | NAMPT, NAPRT, NNT | TDP1 2963/4885ATM 1782/4885VCAM1 3624/4885 |
| US-20230116770-A1 | SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF | NAMPT, NAPRT, NNT | TDP1 2963/4885ATM 1782/4885VCAM1 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.